Your browser doesn't support javascript.
Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9).
Schernthaner, Guntram.
  • Schernthaner G; Department of Medicine, Medical University of Vienna, Vienna, Austria.
Diabetes Metab J ; 45(4): 615-616, 2021 07.
Article in English | MEDLINE | ID: covidwho-1362651

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors / COVID-19 Type of study: Experimental Studies / Prognostic study Limits: Humans Language: English Journal: Diabetes Metab J Year: 2021 Document Type: Article Affiliation country: Dmj.2021.0081

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors / COVID-19 Type of study: Experimental Studies / Prognostic study Limits: Humans Language: English Journal: Diabetes Metab J Year: 2021 Document Type: Article Affiliation country: Dmj.2021.0081